Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reckitt Raises Guidance On Adams Performance, Marketing Momentum

This article was originally published in The Tan Sheet

Executive Summary

Reckitt Benckiser raises its 2008 sales targets based on the performance of brands added with its acquisition of Adams Respiratory Therapeutics early this year and heavy marketing investment in its latest quarter

You may also be interested in...



OTC Innovation Requires Stretching Focus Beyond New Molecules

Complex regulatory schemes, long lead times to launch OTC products and private label competition impede new product development

OTC Innovation Requires Stretching Focus Beyond New Molecules

Complex regulatory schemes, long lead times to launch OTC products and private label competition impede new product development

OTC Innovation Requires Stretching Focus Beyond New Molecules

Complex regulatory schemes, long lead times to launch OTC products and private label competition impede new product development

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102267

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel